Effectiveness of CoronaVac in the prevention of COVID-19, a test-negative case-control study in Brazil
-
Published:2024-09
Issue:5
Volume:28
Page:103856
-
ISSN:1413-8670
-
Container-title:The Brazilian Journal of Infectious Diseases
-
language:en
-
Short-container-title:The Brazilian Journal of Infectious Diseases
Author:
Luna Expedito J.A.ORCID,
Moraes José C.,
Roediger Manuela A.,
Miranda Erique J.F.P.,
Braga Patrícia E.,
França João I.D.,
Pacheco Pedro H.M.,
de Lima Marcos Alves,
Ragiotto LucasORCID,
Barros Eliana N.C.
Funder
Butantan Foundation
Reference15 articles.
1. COVID-19 Vaccine Tracker and Landscape,2023
2. Palácios R, Batista AP, Albuquerque CSN, et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study. Preprint SSRN. https://doi.org/10.2139/ssrn.3822780, [accessed April 14, 2021].
3. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (Coronavac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey;Tanriover;Lancet,2021
4. Brasil/Ministério Da Saúde. Coronavirus, COVID-19, Guia de Vigilância Epidemiológica,2022
5. WHO working group on the clinical characterisation and management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research;Lancet Infect Dis,2020